Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant

Completed · Not applicable · Has a placebo group

Conditions studied: Function of Renal Transplant

In brief

The aim of this study is to evaluate whether peri-transplant administration of a drug named aminophylline to children undergoing a kidney transplant from deceased donors improves early graft function and also projects on long term graft function.

Key facts

Study ID

NCT01759862

Run by

Stanford University

People needed

50

Starts

2012-11-01

Expected to finish

2017-07-25

Last updated by the study team

2019-03-05

Who can join

Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pediatric kidney transplant recipients less than 21 years of age
• Patients undergoing deceased donor (DD) kidney transplants

You may not qualify if…

• Known history of non-sinus tachycardia
• Multiple organ transplants recipients
• Severe liver dysfunction
• graft was placed on pump after harvesting

Where it is running

• Lucile Packard Children's Hospital at Stanford — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.